9 December 2021
The September 2021 BioMed21 regulatory roundtable discussion in India focused on the way forward for the development of human biology-based technologies through sustained funding, training and education, and the in-country development of such technologies. The Centre for Predictive Human Model Systems, a collaboration between Humane Society International/India and the Atal Incubation Centre-Centre for Cellular and Molecular Biology, organized the event as a follow-up to the first scientist roundtable that was held by them in December 2020.
The roundtable brought together key regulators from the Central Drugs Standard Control Organization and the Indian Pharmacopoeia Commission, government bodies like the Indian Council of Medical Research-National Animal Resource Facility and the Committee for the Purpose of Control and Supervision on the Experiments of Animals, and public funding bodies like the Department of Biotechnology, and industry stakeholders to strategize the development and uptake of human biology-based methodologies.
In his remarks, Dr Vinay Nandicoori, Director, CSIR-CCMB, laid emphasis on the importance of stakeholder dialogue involving governments, regulatory bodies, and technology developers to promulgate development of these methodologies in India. The CEO of AIC-CCMB, Dr Madhusudhana Rao affirmed the impetus provided by such meetings to streamline the process of adoption of new model systems in regulatory mandates and drug development. [Read more…]